Dr. Zia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Warren G Magnuson Clinical Center, National Cancer Institute, NIH
9609 Medical Center Drive, 5W-610
Rockville, MD 20850Phone+1 240-276-6142Fax+1 240-276-7888
Summary
- Dr. Farah Zeba Zia is a Board Certified Physician, a practicing Internist and Medical Oncologist, currently working at The National Cancer Institute, Division of Cancer Treatment & Diagnosis, as well as The Center for Cancer Research, Women's Malignancies Branch, and is an active member of The Warren G. Magnuson Clinical Center Medical Staff. Dr. Zia received her Doctor of Medicine Degree from The George Washington University School of Medicine, and subsequently completed a residency in Internal Medicine at The George Washington University Hospital. Thereafter, she completed a fellowship in Hematology/Oncology through The National Cancer Institute & National Heart, Lung, and Blood Institute. During this time, she developed an interest in the treatment of gynecologic malignancies and breast cancer, training under the mentorship of Sandra M. Swain and JoAnne Zujewski. Dr. Zia's continued focus is on gynecologic and breast cancers, clinical trials, drug development, oncology symptom management, and research and development of integrative modalities to enhance the lives of our patients.
Dr. Zia takes part in the education of our next generation of physician/scientists. She is on the faculty of 2 courses that are part of an on-going training curriculum for NIH clinical and post-doctoral fellows, presented by the NCI Center for Cancer Training, within the NCI Office of the Director: (1)Translational Research in Clinical Oncology and (2) Integrative Medicine. Dr. Zia also participates in the Cancer Research Training Award (CRTA) fellowship program, and has successfully mentored several students who have gone on to complete medical school.
Dr. Zia engages in research, development, and support of Integrative Health Modalities to help better the lives of all patients, including those with cancer. She is an active member of a Trans-NIH Committee on Integrative Medicine, using the platform to spear-head initiatives across the NIH and through public-private partnerships.
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2000 - 2003
- George Washington UniversityResidency, Internal Medicine, 1997 - 2000
- George Washington University School of Medicine and Health SciencesClass of 1997
Certifications & Licensure
- VA State Medical License 1999 - 2026
- MD State Medical License 2004 - 2025
- DC State Medical License 1999 - 2013
- American Board of Physician Specialties (ABPS) Internal Medicine
Clinical Trials
- Efficacy and Safety Study of Cediranib in Combination With Olaparib in Patients With Recurrent Platinum-Resistant Ovarian Cancer Start of enrollment: 2017 Jan 17
- Intraperitoneal Infusion of Autologous Monocytes With Sylatron (Peginterferon Alfa-2b) and Actimmune (Interferon Gamma-1b) in Women With Recurrent or Refractory Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer Start of enrollment: 2017 Feb 08
- Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies Start of enrollment: 2022 Jan 04
- Join now to see all
Publications & Presentations
PubMed
- 8 citationsAre psychedelic medicines the reset for chronic pain? Preliminary findings and research needs.Farah Z Zia, Michael H Baumann, Sean J Belouin, Robert H Dworkin, Majid H Ghauri
Neuropharmacology. 2023-08-01 - 2 citationsNational Institutes of Health psilocybin research speaker series: State of the science, regulatory and policy landscape, research gaps, and opportunities.Dan Xi, Ann Berger, David Shurtleff, Farah Z Zia, Sean Belouin
Neuropharmacology. 2023-06-01 - 13 citationsPsychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling.Jack E Henningfield, Marion A Coe, Roland R Griffiths, Sean J Belouin, Ann Berger
Neuropharmacology. 2022-11-01
Press Mentions
- Psychedelics Could Treat Some of the Worst Chronic Pain in the WorldMay 28th, 2024
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: